Literature DB >> 3707114

Failure of vancomycin prophylaxis and treatment for Actinobacillus actinomycetemcomitans endocarditis.

R H Eng, S M Smith, E J Goldstein, K T Miyasaki, S E Quah, F Buccini.   

Abstract

Reported is a case of Actinobacillus actinomycetemcomitans endocarditis which developed after dental prophylaxis with vancomycin and erythromycin. In vitro results indicated that this isolate and 20 additional isolates were resistant to vancomycin and that potentially useful bactericidal antibiotics for the prophylaxis and treatment of A. actinomycetemcomitans infections included gentamicin, sulfamethoxazole-trimethoprim, cefotaxime, and ciprofloxacin.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3707114      PMCID： PMC180469          DOI： 10.1128/AAC.29.4.699

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  Methods of testing combined antibiotic bactericidal action and the significance of the results.

Authors:  L P GARROD; P M WATERWORTH
Journal:  J Clin Pathol       Date:  1962-07       Impact factor: 3.411

2.  Haemophilus aphrophilus infections: clinical and bacteriologic studies.

Authors:  V L Sutter; S M Finegold
Journal:  Ann N Y Acad Sci       Date:  1970-10-30       Impact factor: 5.691

3.  The antibiotic prophylaxis of infective endocarditis. Report of a working party of the British Society for Antimicrobial Chemotherapy.

Authors: 
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

4.  Susceptibility of Bacterium actinomycetem comitans to 45 antibiotics.

Authors:  U Höffler; W Niederau; G Pulverer
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

5.  Bacteremia after the use of an oral irrigation device. A controlled study in subjects with normal-appearing gingiva: comparison with use of toothbrush.

Authors:  S A Berger; S Weitzman; S C Edberg; J I Casey
Journal:  Ann Intern Med       Date:  1974-04       Impact factor: 25.391

6.  Suppression of penicillin-resistant oral Actinobacillus actinomycetemcomitans with tetracycline. Considerations in endocarditis prophylaxis.

Authors:  J Slots; B G Rosling; R J Genco
Journal:  J Periodontol       Date:  1983-04       Impact factor: 6.993

7.  Transient bacteremia and endocarditis prophylaxis. A review.

Authors:  E D Everett; J V Hirschmann
Journal:  Medicine (Baltimore)       Date:  1977-01       Impact factor: 1.889

8.  Penicillin prophylaxis in children with cardiac disease: postextraction bacteremia and penicillin-resistant strains of viridans streptococci.

Authors:  J Hess; Y Holloway; J Dankert
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

9.  Failure of erythromycin in preventing bacterial endocarditis.

Authors:  R H Eng; M Wolff; S M Smith
Journal:  Arch Intern Med       Date:  1982-10

10.  Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease.

Authors:  J J Zambon; J Slots; R J Genco
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441
View more
  3 in total

1.  A clinical view of vancomycin in 1990.

Authors:  W T Siebert
Journal:  Tex Heart Inst J       Date:  1990

2.  Role of high-avidity binding of human neutrophil myeloperoxidase in the killing of Actinobacillus actinomycetemcomitans.

Authors:  K T Miyasaki; J J Zambon; C A Jones; M E Wilson
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

3.  Bactericidal activities of synthetic human leukocyte cathepsin G-derived antibiotic peptides and congeners against Actinobacillus actinomycetemcomitans and Capnocytophaga sputigena.

Authors:  K T Miyasaki; A L Bodeau; J Pohl; W M Shafer
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.